FLC Capital Advisors Purchases New Position in American Healthcare REIT, Inc. (NYSE:AHR)

FLC Capital Advisors purchased a new stake in shares of American Healthcare REIT, Inc. (NYSE:AHR) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 20,644 shares of the company’s stock, valued at approximately $539,000.

Several other institutional investors and hedge funds have also bought and sold shares of AHR. Principal Financial Group Inc. purchased a new stake in American Healthcare REIT in the 1st quarter worth approximately $88,504,000. Centersquare Investment Management LLC purchased a new stake in American Healthcare REIT in the 1st quarter worth approximately $63,269,000. V3 Capital Management L.P. purchased a new stake in American Healthcare REIT in the 1st quarter worth approximately $42,337,000. Goldentree Asset Management LP purchased a new stake in American Healthcare REIT in the 1st quarter worth approximately $22,125,000. Finally, Russell Investments Group Ltd. purchased a new stake in American Healthcare REIT in the 1st quarter worth approximately $20,381,000. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. JMP Securities increased their target price on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research note on Friday, September 20th. Bank of America increased their target price on shares of American Healthcare REIT from $27.00 to $31.00 and gave the stock a “buy” rating in a research note on Tuesday, September 24th. Morgan Stanley raised their price objective on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, August 22nd. Colliers Securities upgraded shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research report on Sunday. Finally, Truist Financial raised their price objective on shares of American Healthcare REIT from $22.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, September 20th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $23.00.

American Healthcare REIT Stock Performance

AHR stock opened at $25.41 on Thursday. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.60. American Healthcare REIT, Inc. has a 52 week low of $12.63 and a 52 week high of $26.77. The firm’s fifty day moving average is $22.66 and its 200 day moving average is $17.48.

American Healthcare REIT (NYSE:AHR) last released its earnings results on Monday, August 5th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.28). American Healthcare REIT had a negative net margin of 1.99% and a negative return on equity of 2.20%. The business had revenue of $504.60 million for the quarter, compared to the consensus estimate of $506.55 million. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. On average, sell-side analysts forecast that American Healthcare REIT, Inc. will post 1.31 EPS for the current fiscal year.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 18th. Shareholders of record on Friday, September 20th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 3.94%. The ex-dividend date of this dividend is Friday, September 20th.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.